CHICAGO, United States (Bernama): Drugmaker Pfizer-BioNTech announced Thursday (July 8) that it is working on a Covid-19 vaccine to target the Delta variant and will begin clinical trials in August in case it is needed.
Some industry experts have warned that profit could be more a motivating factor for drug companies eager to get new vaccines approved by the US Food and Drug Administration (FDA).
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
